Due to the automatic nature of our procedure, we believe this approach could be readily applied to other types of cancer where the abundance/location of CD8+ T lymphocytes (or any type of non-cancer cells) is likely to be an indicator of prognosis. The gene discussed is CD8A; the disease is cancer.